Suzuken Co Ltd
TSE:9987
Intrinsic Value
Suzuken Co., Ltd. engages in the pharmaceutical business. [ Read More ]
The intrinsic value of one Suzuken Co Ltd stock under the Base Case scenario is 14 944.98 JPY. Compared to the current market price of 4 503 JPY, Suzuken Co Ltd is Undervalued by 70%.
Valuation Backtest
Suzuken Co Ltd
Run backtest to discover the historical profit from buying and selling Suzuken Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Suzuken Co Ltd
Current Assets | 1T |
Cash & Short-Term Investments | 242.1B |
Receivables | 585.7B |
Other Current Assets | 202.7B |
Non-Current Assets | 273.8B |
Long-Term Investments | 93.6B |
PP&E | 128.5B |
Intangibles | 12.6B |
Other Non-Current Assets | 39.2B |
Current Liabilities | 869.1B |
Accounts Payable | 825B |
Accrued Liabilities | 5.2B |
Other Current Liabilities | 39B |
Non-Current Liabilities | 24.3B |
Other Non-Current Liabilities | 24.3B |
Earnings Waterfall
Suzuken Co Ltd
Revenue
|
2.4T
JPY
|
Cost of Revenue
|
-2.2T
JPY
|
Gross Profit
|
183.7B
JPY
|
Operating Expenses
|
-149B
JPY
|
Operating Income
|
34.7B
JPY
|
Other Expenses
|
-7B
JPY
|
Net Income
|
27.7B
JPY
|
Free Cash Flow Analysis
Suzuken Co Ltd
Profitability Score
Profitability Due Diligence
Suzuken Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Suzuken Co Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Suzuken Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Suzuken Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Suzuken Co Ltd
According to Wall Street analysts, the average 1-year price target for Suzuken Co Ltd is 4 814.4 JPY with a low forecast of 3 939 JPY and a high forecast of 5 460 JPY.
Shareholder Return
Price
Suzuken Co Ltd
Average Annual Return | -12.23% |
Standard Deviation of Annual Returns | 14.97% |
Max Drawdown | -55% |
Market Capitalization | 353.3B JPY |
Shares Outstanding | 73 367 337 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Suzuken Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nagoya, Aichi-Ken and currently employs 15,041 full-time employees. The firm operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Contact
IPO
Employees
Officers
The intrinsic value of one Suzuken Co Ltd stock under the Base Case scenario is 14 944.98 JPY.
Compared to the current market price of 4 503 JPY, Suzuken Co Ltd is Undervalued by 70%.